Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to β-sheet in amyloid fibril formation.
Amyloid cascades that lead to peptide β-sheet fibrils and plaques are central to many important diseases. Recently, intermediate assemblies of these cascades were identified as the toxic agents that interact with cellular machinery. The location and cause of the transformation from a natively unstructured assembly to the β-sheet oligomers found in all fibrils is important in understanding disease onset and the development of therapeutic agents. Largely, research on this early oligomeric region was unsuccessful because all the traditional techniques measure only the average oligomer properties of the ensemble. We utilized ion-mobility methods to deduce the peptide self-assembly mechanism and examined a series of amyloid-forming peptides clipped from larger peptides or proteins associated with disease. We provide unambiguous evidence for structural transitions in each of these fibril-forming peptide systems and establish the potential of this method for the development of therapeutic agents and drug evaluation.
Department of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106-9510, USA.
Christian
C
Bleiholder
Nicholas F
NF
Dupuis
Thomas
T
Wyttenbach
Michael T
MT
Bowers
D000595:Amino Acid Sequence; D000682:Amyloid / Q000737:chemistry* / Q000235:genetics; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D008958:Models, Molecular; D010455:Peptides / Q000737:chemistry / Q000235:genetics; D017433:Protein Structure, Secondary
D000682:Amyloid; D010455:Peptides
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53
9600986
Biopolymers. 1996;40(1):121-39
8541444
Nature. 1993 Nov 25;366(6453):324-7
8247126
Science. 1993 Jun 4;260(5113):1446-51
17739800
Nature. 1995 Jan 5;373(6509):37-43
7800037
Curr Opin Struct Biol. 2007 Feb;17(1):48-57
17251001
Nature. 2002 Apr 4;416(6880):507-11
11932737
Acc Chem Res. 2006 Sep;39(9):568-75
16981672
Mass Spectrom Rev. 1997 Jan-Feb;16(1):1-23
9414489
Trends Biochem Sci. 2004 Oct;29(10):542-7
15450609
Chemistry. 2003 Jun 16;9(12):2676-83
12772282
Protein Sci. 2000 Feb;9(2):427-31
10716196
J Am Chem Soc. 2009 Dec 30;131(51):18283-92
19950949
Science. 1988 May 27;240(4856):1177-81
2453923
Protein Pept Lett. 2006;13(3):255-60
16515453
J Neurosci Res. 2002 Sep 1;69(5):567-77
12210822
Nature. 2007 May 24;447(7143):453-7
17468747
Science. 2005 Dec 9;310(5754):1658-61
16293722
Nat Chem. 2009 Jul;1(4):326-31
20703363
Nat Chem Biol. 2009 Jan;5(1):15-22
19088715
Nature. 2005 Jun 9;435(7043):773-8
15944695
Science. 1978 Mar 17;199(4334):1214-6
204006
Nat Struct Mol Biol. 2008 Jun;15(6):558-66
18511942
Angew Chem Int Ed Engl. 2007;46(43):8128-47
17935097
Mol Neurodegener. 2007 Sep 26;2:18
17897471
J Struct Biol. 2000 Jun;130(2-3):88-98
10940217
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
17245412
Trends Biochem Sci. 2007 May;32(5):217-24
17412596
Biochim Biophys Acta. 2009 Mar;1794(3):375-97
19071235
Curr Opin Struct Biol. 2006 Apr;16(2):260-5
16563741
Angew Chem Int Ed Engl. 2001 Mar 16;40(6):988-1011
11268062
Biophys J. 2000 Aug;79(2):1053-65
10920035
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17342-7
16293696
Science. 1995 Mar 10;267(5203):1483-5
17743549
Angew Chem Int Ed Engl. 2005 May 20;44(21):3297-301
15830332
Science. 2003 Apr 18;300(5618):486-9
12702875